Advertisement

Rating Scales for Adverse Drug Reactions

  • Per Bech

Abstract

For the various treatment modalities in psychiatry (e.g. psychotherapy or pharmacotherapy) the monitoring of adverse drug reactions has been a subject of intense interest, although scales for measuring side effects of psychopharmacological drugs have only recently been designed. On the other hand, the confession of “nonexistent” life events as a rational part of some types of psychoanalytical therapy has only very rarely been studied in terms of side effects of treatment, although Janet (1923) early observed problems in treating depressed patients with confessional psychoanalysis, a method Frank (1984) has compared to “brain washing”.

Keywords

Adverse Drug Reaction System Organ Class Nervous System Disorder Appendage Disorder Extrapyramidal Symptom Rate Scale 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ayd FJ. The impact of biological psychiatry. In: Ayd FJ, Blackwell B. (eds). Discoveries in Biological Psychiatry. Philadelphia: Lippincott, 1970, pp. 230–243.Google Scholar
  2. Bech P. Rating scales for mood disorders: applicability, consistency and construct validity. Acta Psychiat Scand 1988; 78(suppl. 345): 45–55.Google Scholar
  3. Bech P, Vendsborg PB, Rafaelsen OJ. Lithium maintenance treatment of manic-melancholic patients: its role in the daily routine. Acta Psychiat Scand 1976; 53: 70–81.PubMedCrossRefGoogle Scholar
  4. Bech P, Thomsen J, Prytz S, Vendsborg PB, Zilstorff K, Rafaelsen OJ. The profile and severity of lithium-induced side effects in mentally healthy subjects. Neuropsychobiology 1979; 5: 160–166.PubMedCrossRefGoogle Scholar
  5. Bischoff R, Bobon D, Görtelmeyer R, Horn R, Müller AA, Stoll KD, Cade JFJ. Lithium salts in the treatment of psychotic excitement. Med J Aust 1949; 36: 349–351.Google Scholar
  6. Bobon D, Baumarm U, Angst J, Helmchen H, Hippius H. AMDP-system in pharmacopsychiatry. Basel: Karger, 1983.Google Scholar
  7. Carroll BJ, Fielding JM, Blaski TG. Depression rating scales: a critical review. Arch Gen Psychiat 1973; 28: 361–366.PubMedCrossRefGoogle Scholar
  8. Chouinard G, Ross-Chouinard A, Annable L, Jones BD. Extrapyramidal Symptom Rating Scale. Can J Neurol Sci 1980; 7:233–239.Google Scholar
  9. Cocchetto DM, Nardi RV. Benefit-risk assessment of investigational drugs: Current methodology, limitations and alternative approaches. Science for clinicians. Pharmacology 1986; 6:286–303.Google Scholar
  10. Cochran SD. Preventing medical noncompliance in the outpatient treatment of bipolar affective disorders. J Cons Clin Psychol 1984; 5: 873–878.CrossRefGoogle Scholar
  11. Cochran SD, Gitlin MJ. Attitudinal correlates of lithium compliance in bipolar affective disorders. J Nerv Ment Dis 1988; 176:457–464.PubMedCrossRefGoogle Scholar
  12. Conduct of Clinical Trials of Medical Products (CPMP). Good clinical practice for trials on medical products in the European Community. Brussels: Commission of the European Communities, 1990.Google Scholar
  13. Delay J, Deniker P. 38 cas de psychose traitées par la cure prolongée et continué de 4560 RP. Le Congres de Psychiat Neurol de Langue Francaise. Luxembourg: Masson, 1952, pp. 503–513.Google Scholar
  14. Drowning RW, Rickeis K, Meyers F. Side reactions in neurotics: a comparison of two methods of assessment. J Clin Pharmacology 1970; 10: 289–297.CrossRefGoogle Scholar
  15. Faich GA. Adverse drug reaction monitoring. N Engl J Med 1986; 314: 1589–1592.PubMedCrossRefGoogle Scholar
  16. Food and Drug Administration (FDA). Procedural manual for handling drug experience reports. Glossary paper flow and algorithms. Rockville: Dept Health Human Serv, 1980.Google Scholar
  17. Frank JD. The effects of psychotherapy. In.: Meyers JM (ed). Cures by Psychotherapy. New York, Praeger Publishers, 1984.Google Scholar
  18. Gelberg A, Armstrong GD, Dreis MB, Anello C. Technology developments with the FDA adverse drug reaction file system. Drug Inform J 1991; 25: 19–28.Google Scholar
  19. Gerlach J, Korsgaard S. Classification of abnormal involuntary movements in psychiatric patients. Neuropsychiat Clin 1983; 2: 201–208.Google Scholar
  20. Gerlach J, Korsgaard S, Clemmesen P. The Sanct Hans Rating Scale for Extrapyramidal Syndromes: Reliability and Validity. Acta Psychiat Scand 1992 (in press).Google Scholar
  21. Gjerris A, Bech P, Broen-Christensen C, Geisler A, Klysner R, Rafaelsen OJ. Haloperidol plasma levels in relation to antimanic effect. In: Usdin E, Dahl S, Gram LF (eds). Clinical Pharmacology in Psychiatry. London, MacMillan Press, 1980.Google Scholar
  22. Goodwin FK, Jamison KR. Manic-Depressive Illness. New York, Oxford University Press 1990.Google Scholar
  23. Gordis L. Conceptual and methodological problems in measuring compliance. In: Haynes RB, Taylor DW, Sackett DL (eds). Compliance in Health Care. Baltimore: Johns Hopkins University Press, 1979, pp. 23–45.Google Scholar
  24. Guy W. Early Clinical Drug Evaluation (ECDEU) assessment manual for psychopharmacology. Rockville, Nat Inst Ment Health, 1976.Google Scholar
  25. Guy W, Bonato RR. Manual for the Early Clinical Drug Evaluation (ECDEU) assessment battery. Maryland, Nat Inst Ment Health, 1970.Google Scholar
  26. Guy W, Ban TA. The assessment and documentation of psychopathology. Berlin, Springer, 1982.Google Scholar
  27. Hall RA, Jackson RB, Swain JM. Neurotoxic reactions resulting from chlorpromazine administration. J Am Med Ass 1956; 161: 214–218.CrossRefGoogle Scholar
  28. Harvey P. Health Psychology. London, Longman 1988.Google Scholar
  29. Janet P. La medicine psychologique. Paris, Alcan, 1923.Google Scholar
  30. Kline NS. Monoamine oxydase inhibitors: An unfinished picaresque tale. In: Ayd FJ, Blackwell B (eds.). Discoveries in Biological Psychiatry. Philadelphia, J. B. Lippincott 1970, pp. 459–464.Google Scholar
  31. Kuhn R. The imipramine story. In: Ayd FJ, Blackwell B (eds). Discoveries in Biological Psychiatry. Philadelphia, Lippincott, 1970, pp. 205–217.Google Scholar
  32. Kuhn R. Ober die Wandlung depressiver Zustände mit einem Iminodibenzylderivat (G 22355). Schw Med Wschr 1957; 87:1135–1140.Google Scholar
  33. Kuhn R. The treatment of depressive states with G 22355 (imipramine hydrochloride). Am J Psychiatry 1958; 115: 459–464.PubMedGoogle Scholar
  34. Levine J. Assessment of side-effects. In: Benkert O, Maier W, Rickeis K (eds). Methodology of the evaluation of psychotropic drugs. Berlin, Springer 1990, pp. 130–135.Google Scholar
  35. Lingjærde O, Ahlfors UG, Bech P, Dencker SJ, Eigen K. The UKU side effect rating scale. Acta Psychiat Scand 1987; 76(suppl 334): 1–100.CrossRefGoogle Scholar
  36. Pogge RC. The toxic placebo. Medical Times 1963; 91: 773–781.PubMedGoogle Scholar
  37. Schonecker M. Ein eigentümliches Syndrome im oralen Bereich bei Megaphenaplikation. Nervenartz 1957; 28:35.Google Scholar
  38. Schou M, Juel-Nielsen N, Strömgren E, Voldby H. The treatment of manic psychoses by the administration of lithium salts. J Neurol Neurosurg Psychiat 1954; 17: 250–260.PubMedCrossRefGoogle Scholar
  39. Simpson GM, Angus JWS. A rating scale for extrapyramidal side effects. Acta Psychiat Scand 1970; 46(suppl 212): 11–19.CrossRefGoogle Scholar
  40. Steck, 1954 (cited by Deniker P.). Introduction of neuroleptic chemotherapy into psychiatry. In: Ayd FJ, Blackwell B (eds). Discoveries in biological psychiatry. Philadelphia, Lippincott, 1979, pp. 155–164.Google Scholar
  41. Stephens MDB. The detection of new adverse drug reactions. London, The MacMillan Press, 1988.Google Scholar
  42. Woggon B. Rating scales for psychiatry. European Edition. Hembach, Beltz Test, 1990.Google Scholar
  43. World Health Organization. WHO Adverse Reaction Terminology. Geneva, World Health Organization, 1990.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • Per Bech
    • 1
  1. 1.Department of PsychiatryFrederiksborg General HospitalHillerødDenmark

Personalised recommendations